JOHNSON & Johnson’s US wing
has been hit by its 11th recall this
year, after its artificial joint business
was forced to recall two of its artificial
joint hip replacement products, the
ASR Hip Resurfacing System and
the ASR XL Acetabular System.
According to reports the recall
follows evidence that one in eight
patients fitted with the products
had to undergo revision surgery.The above article was sent to subscribers in Pharmacy Daily's issue from 27 Aug 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 Aug 10
MEDICATION management platform MedAdvisor Limited (MDR) showed strong financial performance for the quarter concluded on 31 Mar 2024, with operating revenue up 42% to $24.2 million from $17 million for the same period last year.
PHARMACIES in regional areas need a restructure of the 8CPA Community Service Obligation (CSO) to help fund them to support their workforce and deliver services, says the Remote and Isolated Pharmacist Association Australia (RIPAA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.